Respiratory failure
474 results
201 - 300
Ebstein's anomaly and tricuspid regurgitation - Audio 
Surfactant for meconium aspiration syndrome in term and late preterm infants- Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation
- Respiratory muscle training for multiple sclerosis
Drotrecogin ineffective in septic children (RESOLVE)- High‐flow nasal cannula therapy for respiratory support in children
- Treatment of poisoning
- High frequency oscillatory ventilation versus conventional ventilation for infants with severe pulmonary dysfunction born at or near term
- Care bundles for improving outcomes in patients with COVID‐19 or related conditions in intensive care – a rapid scoping review
- Acute heart failure and pulmonary oedema
- Epidural pain relief versus systemic opioid‐based pain relief for abdominal aortic surgery
- Broad-spectrum abx increase adverse events in children with acute respiratory infections with minimal benefit
- Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants
- Respiratory muscle training in children and adults with neuromuscular disease
- Short-course antibiotics for acute otitis media: Cochrane systematic review
- Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome
- New definition of sepsis, new bedside screen to identify patients at high-mortality risk
- Carnitine supplementation for preterm infants with recurrent apnoea
- Nebulized racemic epinephrine for extubation of newborn infants
- Oxygen via high-flow nasal cannula reduces the need for intubation in patients with severe COVID-19
- Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
- Despite no evidence, the ATS issues a guideline on managing obesity hypoventilation syndrome
- Multisystem inflammatory syndrome in children (MIS-C) with COVID-19 infection
- Inhaled anticholinergics and short-acting beta 2 -agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital: Cochrane systematic review
- The acutely ill infant (below 6 months)
- Nasal high flow therapy for primary respiratory support in preterm infants
- Venous samples are a less-painful starting point for the evaluation of patients with AECOPD
- Idiopathic pulmonary fibrosis
- Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline
- Non‐invasive high‐frequency ventilation in newborn infants with respiratory distress
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Preoperative assessment
- Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
- Pharmacological treatment for central sleep apnoea in adults
- High‐flow nasal cannulae for respiratory support in adult intensive care patients
- Less renal replacement therapy with sodium bicarbonate infusion for patients with severe metabolic acidosis
- Increased blood creatinine concentration, eGFR and renal function tests
- Chronic non‐invasive ventilation for chronic obstructive pulmonary disease
- Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
- Combined inhaled anticholinergics and short-acting beta 2 -agonists for initial treatment of acute asthma in children: Cochrane systematic review
- Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome
- Sleep apnoea in the adult
- Pneumonia
- Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants
- Conservative oxygenation strategy reduces mortality in critically ill patients
- N‐acetylcysteine for sepsis and systemic inflammatory response in adults
- Bubble devices versus other pressure sources for nasal continuous positive airway pressure in preterm infants
- Antibiotics for bronchiolitis in children under two years of age: Cochrane systematic review
- Prophylactic methylxanthines for endotracheal extubation in preterm infants: Cochrane systematic review
- Lung cancer is infrequently found via screening, but follow-up imaging is common
- Myositis
- Facial fractures
- Neuroleptic malignant syndrome (NMS)
- Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation
- Mixed outcomes with early extubation to noninvasive ventilation for difficult-to-wean patients
- Blood transfusion for treating malarial anaemia: Cochrane systematic review
- Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates
- Diuretics for respiratory distress syndrome in preterm infants
- Corticosteroids for pneumonia
- Strategies for the discontinuation of humidified high flow nasal cannula (HHFNC) in preterm infants: Cochrane systematic review
- Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults
- Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia
- Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation
- Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
- COVID-19 research briefs: case series of critically ill patients in the intensive care unit
- Silicosis
- Clinician‐targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
- Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery
- Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants
- Drugs commonly causing poisonings
- Oral steroids for long‐term use in cystic fibrosis
- Diving medicine
- Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
- In-office procalcitonin testing can lead to less antibiotic prescribing
- Antibiotics for persistent nasal discharge (rhinosinusitis) in children: Cochrane systematic review
- Deep vein thrombosis
- Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
- Endovascular treatment for ruptured abdominal aortic aneurysm
- Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age
- Prone position is difficult to maintain and may be ineffective in non-ICU patients with COVID-19
- Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome
- Extended rivaroxaban prophylaxis following a medical inpatient stay does not provide a net benefit (MARINER)
- No benefit to extended VTE prophylaxis with apixaban in hospitalized medical patients (ADOPT)